Alpha Teknova (Alpha Teknova) EBIT : $-30.24 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alpha Teknova EBIT?

Alpha Teknova's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was $-7.99 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was $-30.24 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Alpha Teknova's annualized ROC % for the quarter that ended in Mar. 2024 was -33.99%. Alpha Teknova's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -41.12%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Alpha Teknova's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -36.15%.

Alpha Teknova EBIT Historical Data

The historical data trend for Alpha Teknova's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alpha Teknova EBIT Chart

Alpha Teknova Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

-1.86

4.66

-12.01

-28.86

-31.20

Alpha Teknova Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT	Get a 7-Day Free Trial													-8.95	-4.80	-8.76	-8.69	-7.99

Competitive Comparison of Alpha Teknova's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Alpha Teknova's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alpha Teknova's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alpha Teknova's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Alpha Teknova's EV-to-EBIT falls into.

Alpha Teknova EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-30.24 Mil.

Alpha Teknova (NAS:TKNO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Alpha Teknova's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

	ROC % (Q: Mar. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Mar. 2024 ))	/ count )
=	-31.944 * ( 1 - 0.42% )	/	( (93.047	+	94.134)	/ 2 )
=	-31.8098352	/	93.5905
=	-33.99 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	128.587	-	7.056	-	( 28.484	-	max(0, 8.875	-	45.66	+	28.484	))
=	93.047

	Invested Capital		(Q: Mar. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	120.817	-	5.087	-	( 21.596	-	max(0, 7.039	-	38.823	+	21.596	))
=	94.134

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Alpha Teknova's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Mar. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-31.944	/	( ( (66.836 + max(10.104, 0))	+	(66.307 + max(12.11, 0)) )	/	2 )
=	-31.944	/	( ( 76.94	+	78.417 )	/	2 )
=	-31.944	/	77.6785
=	-41.12 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(3.948	+	11.594	+	1.634)	-	(7.056	+	0.016	+	0)
=	10.104

	Working Capital		(Q: Mar. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(4.56	+	11.207	+	1.46)	-	(5.087	+	0.03	+	0)
=	12.11

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Alpha Teknova's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2024 )
	=	-30.239	/	83.654
	=	-36.15 %

Alpha Teknova EBIT Related Terms

Thank you for viewing the detailed overview of Alpha Teknova's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Alpha Teknova (Alpha Teknova) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alpha Teknova Inc (NAS:TKNO) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

2451 Bert Drive, Hollister, CA, USA, 95023

Website

https://www.teknova.com

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.

Executives

Ken Gelhaus	officer: Chief Commercial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Stephen Gunstream	director, officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
J Matthew Mackowski	director	343 SANSOME ST, SUITE 1215, SANSASAN FRANCISCO CA 94104
Matthew Lowell	officer: Chief Financial Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Damon Terrill	officer: See Remarks	2290 BERT DRIVE, HOLLISTER CA 95023
Thp Iv Affiliates Fund, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108
Martha J Demski	director	7770 REGENTS ROAD SUITE 113-505, SAN DIEGO CA 92122
Lisa Hood	officer: Chief People Officer	2290 BERT DRIVE, HOLLISTER CA 95023
Irene Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Ted Davis	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Iv, L.p.	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO MA 94108
Paul David Grossman	director	1600 FARADAY AVENUE, CARLSBAD CA 92008
Brett Robertson	director	C/O INVUITY, INC., 444 DE HARO STREET, SAN FRANCOSCO CA 94107
Alexander C. Herzick	director	2290 BERT DRIVE, HOLLISTER CA 95023
Telegraph Hill Partners Management Company, Llc	10 percent owner	360 POST STREET, SUITE 601, SAN FRANCISCO CA 94108